Data / Form D filings / Edenbridge Holdings LLC
Edenbridge Holdings LLC: Form D filing
Edenbridge Holdings LLC, a pharmaceuticals company in New York, NY, filed a Form D with the SEC in 2017. The latest, on January 26, 2017, reports $15.4 million sold of an offering with no set size to 10 investors.
Find out what Edenbridge Holdings LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- C/O TAILWIND MANAGEMENT LP, 485 LEXINGTON AVENUE, 23RD FLOOR, New York, NY, 10017
- Phone
- (212) 271-3800
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- $25,000,001 - $100,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1695445
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 26, 2017 | New notice | Indefinite | $15,407,875 | Indefinite | 10 | Jan 11, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frank S. Sica | Director | |
| Kevin S. Connelly | Director | |
| James S. Hoch | Executive Officer | |
| Kamal S. Maruf | Director | |
| M. Ryan S. Collins | Executive Officer, Director | |
| Joseph S. Leary | Director | |
| Patrick S. Chu | Executive Officer, Director | |
| Geoffrey S. Raker | Executive Officer, Director |
Other pharmaceuticals companies in New York that filed recently
- NBO Pharma Inc. $238,000 · Nov 9, 2026
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Jan 23, 2017 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Edenbridge Holdings LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.